[CQM-6833] 143 Question Created: 03/15/24 Updated: 03/28/24 Resolved: 03/28/24 |
|
| Status: | Closed |
| Project: | eCQM Issue Tracker |
| Component/s: | None |
| Type: | EC eCQMs - Eligible Clinicians | Priority: | Moderate |
| Reporter: | Kaitlin Miller (Inactive) | Assignee: | Mathematica EC eCQM Team (Inactive) |
| Resolution: | Answered | Votes: | 0 |
| Labels: | None | ||
| Contact Name: | Kaitlin Miller |
| Contact Email: | kaitlin.miller@oneoncology.com |
| Contact Phone: | 3306207769 |
| Solution: | Thank you for your question on CMS157v12/QID#143: Oncology: Medical and Radiation - Pain Intensity Quantified. The measure requires quantifying pain intensity using a standard instrument at each eligible patient-physician interaction. Pain assessments using non-standard tools should not meet the measure.
|
| Solution Posted On: | |
| 2024 Performance Period EC eCQMs: |
CMS0157v12
|
| Impact: | performance |
| Description |
|
For eCQM measure #143, If you switch pain scales in the middle of a performance year from an unvalidated to a validated tool, would this be an acceptable use case for the unvalidated pain screenings being considered incomplete as the pain severity is otherwise not documented and for reason not otherwise specified i.e. due to invalid tool used? |
| Comments |
| Comment by Mathematica EC eCQM Team (Inactive) [ 03/25/24 ] |
|
We continue to investigate the issue noted in your ticket and will provide a response as soon as we are able. Thank you for your patience. |
| Comment by Mathematica EC eCQM Team (Inactive) [ 03/18/24 ] |
|
Thank you for submitting your question. We will review your ticket and provide a response as soon as possible. |